$VRTX.US – Vertex Pharmaceutical Inc ranked positive on August 24, 2021

$VRTX.US – Vertex Pharmaceutical Inc ranked positive on August 24, 2021

Reshma Kewalramani (Vertex Pharmaceutical Inc CEO since 2020, joined 2018) purchased $2.0 million of stock on the 19th August at $195.65, increasing his holding by 16%. This is a notable trade as it is his first buy since joining the company and he has been a regular seller of options and stock via 10b5-1 program sales.

Bruce Sachs (Lead Independent Director since 1998) bought $3.0 million of stock on the 2nd of August, despite his long tenure this is only his 2nd purchase in the stock since 2008.

These purchases from rare buyers are very encouraging.

We are ranking the stock +1.

If you want to have Stock of the Week with insider buying stocks information and analysis in your email right in time, don’t forget to subscribe!
Follow us on LinkedIn and Twitter

If you are interested in our Stocks of the Week
those services may also be useful for you


Timely data delivery customised to every user, backed by analysis tools on our internal website


We rank the stocks where transactions are most likely to indicate future share price performance


Studying buyback activity can give a clue to the fortunes of a company and help predict future share price movement

If you are a member of the media and would like to speak with a Smart Insider expert, please contact us press@smartinsider.com or call +44 203 405 3356

Scroll to Top